Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. UPLOAD Other SEC-generated Letter
  2. S-3 Offering Registration Statement
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Shareholder vote results
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Other events
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 18 of 23 · 442 filings